These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 24910450

  • 1. Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions.
    Lieury A, Chanal M, Androdias G, Reynolds R, Cavagna S, Giraudon P, Confavreux C, Nataf S.
    Glia; 2014 Oct; 62(10):1645-58. PubMed ID: 24910450
    [Abstract] [Full Text] [Related]

  • 2. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S, Frischer JM, Lassmann H, Koch-Henriksen N, Lucchinetti CF, Sørensen PS, Laursen H.
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [Abstract] [Full Text] [Related]

  • 3. Immunopathology of secondary-progressive multiple sclerosis.
    Prineas JW, Kwon EE, Cho ES, Sharer LR, Barnett MH, Oleszak EL, Hoffman B, Morgan BP.
    Ann Neurol; 2001 Nov; 50(5):646-57. PubMed ID: 11706971
    [Abstract] [Full Text] [Related]

  • 4. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
    Gilmore CP, Geurts JJ, Evangelou N, Bot JC, van Schijndel RA, Pouwels PJ, Barkhof F, Bö L.
    Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
    [Abstract] [Full Text] [Related]

  • 5. Sodium channel expression within chronic multiple sclerosis plaques.
    Black JA, Newcombe J, Trapp BD, Waxman SG.
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):828-37. PubMed ID: 17805013
    [Abstract] [Full Text] [Related]

  • 6. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.
    Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N.
    Brain; 2009 May; 132(Pt 5):1190-9. PubMed ID: 19420101
    [Abstract] [Full Text] [Related]

  • 7. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [Abstract] [Full Text] [Related]

  • 8. A Unique TGFB1-Driven Genomic Program Links Astrocytosis, Low-Grade Inflammation and Partial Demyelination in Spinal Cord Periplaques from Progressive Multiple Sclerosis Patients.
    Nataf S, Barritault M, Pays L.
    Int J Mol Sci; 2017 Oct 05; 18(10):. PubMed ID: 28981455
    [Abstract] [Full Text] [Related]

  • 9. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
    Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H.
    Ann Neurol; 1998 Apr 05; 43(4):465-71. PubMed ID: 9546327
    [Abstract] [Full Text] [Related]

  • 10. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD, Vignos M, Dudman J, Chang A, Fisher E, Staugaitis SM, Battapady H, Mork S, Ontaneda D, Jones SE, Fox RJ, Chen J, Nakamura K, Rudick RA.
    Lancet Neurol; 2018 Oct 05; 17(10):870-884. PubMed ID: 30143361
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular signature of slowly expanding lesions in progressive multiple sclerosis.
    Jäckle K, Zeis T, Schaeren-Wiemers N, Junker A, van der Meer F, Kramann N, Stadelmann C, Brück W.
    Brain; 2020 Jul 01; 143(7):2073-2088. PubMed ID: 32577755
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.
    Brain; 2007 May 01; 130(Pt 5):1224-34. PubMed ID: 17405762
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extensive hippocampal demyelination in multiple sclerosis.
    Geurts JJ, Bö L, Roosendaal SD, Hazes T, Daniëls R, Barkhof F, Witter MP, Huitinga I, van der Valk P.
    J Neuropathol Exp Neurol; 2007 Sep 01; 66(9):819-27. PubMed ID: 17805012
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.
    J Neuropathol Exp Neurol; 2007 Aug 01; 66(8):732-9. PubMed ID: 17882017
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.